Neuroscience News and Research

RSS

Evidence suggests two patterns of early symptoms precede and predict later BD risk

Two patterns of antecedent or "prodromal" psychiatric symptoms may help to identify young persons at increased risk of developing bipolar disorder (BD), according to a new analysis in the Harvard Review of Psychiatry.

12 Jan 2018

Study finds overall pattern of commonality between Huntington's and Parkinson's

A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases.

12 Jan 2018

New study discovers key brain circuit implicated in social behavior

A new study by researchers at Roche in Basel, Switzerland has identified a key brain region of the neural circuit that controls social behavior. Increasing the activity of this region, called the habenula, led to social problems in rodents, whereas decreasing activity of the region prevented social problems.

11 Jan 2018

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer’s disease and Parkinson’s disease.

11 Jan 2018

Kessler Foundation researcher receives grant for study on emotional processing intervention in MS

Helen Genova, PhD, Assistant Director of Neuropsychology & Neuroscience Research at Kessler Foundation, has been awarded a $44,000 grant from the National Multiple Sclerosis Society.

10 Jan 2018

Family study looks at potential genetic distinctions between bipolar disorder subtypes

The most common subtypes of bipolar disorder, bipolar I and bipolar II, stem-at least in part-from different biological causes, according to a new study published in Biological Psychiatry.

10 Jan 2018

Salk scientists identify molecular target of experimental Alzheimer’s drug

The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.

10 Jan 2018

Alzheimer’s Research UK calls on pharma to continue supporting dementia research

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.

10 Jan 2018

Vanderbilt and Lundbeck collaborate to develop novel approach for treating schizophrenia

Vanderbilt University has signed separate licensing and research collaboration agreements with Lundbeck, a global pharmaceutical company based in Denmark, to develop a novel approach for treating schizophrenia.

9 Jan 2018

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

By the end of 2019, Regeneron plans to sequence the exomes of all 500,000 people within the UK Biobank resource, all with associated health records, creating an unprecedented resource linking human genetic variations to human biology and disease.

9 Jan 2018

Researchers develop drug that supports cellular traffic jam theory in ALS/FTD

Neurodegeneration in ALS/FTD may be caused by TDP-43 aggregation in the cytoplasm, causing cellular traffic jams. The trial drug can sequester TDP-43.

9 Jan 2018

WPI professor receives Smith Family Foundation grant to explore biology of cancer cells

Amity Manning, assistant professor of biology and biotechnology, has received a three-year, $300,000 award from the Smith Family Awards Program for Excellence in Biomedical Research.

8 Jan 2018

Social difficulties of females with autism may be masked during clinical assessments, study finds

On parent-reporting measures, girls with autism seem to struggle more than boys with performing routine tasks like getting up and dressed or making small talk, even when the study group is normalized to meet similar basic clinical diagnostic criteria across sexes.

5 Jan 2018

Sleeping sickness actually caused by acceleration of biological clocks

Sleeping sickness could use a more encompassing moniker. An international study from the O'Donnell Brain Institute shows one of Africa's most lethal diseases is actually a circadian rhythm disorder caused by the acceleration of biological clocks controlling a range of vital functions besides sleep.

4 Jan 2018

Powerful imaging technique sheds light on how the brain responds to vascular injury

Pericytes, a little-understood type of cell on the brain's blood vessels, grow into the empty space left when neighboring pericytes die, report researchers at the Medical University of South Carolina in a January 2nd, 2018 article in Cell Reports.

4 Jan 2018

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Jan 2018

Advanced live cell imaging reveals brain’s response to blood vessel injury

Live cell imaging and laser beam ablation reveals the damage response of pericytes surrounding blood vessels in the brain.

3 Jan 2018

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Dec 2017

New AAN guideline: Exercising twice a week may improve memory in people with MCI

Exercising twice a week may improve thinking ability and memory in people with mild cognitive impairment (MCI), according to a guideline released by the American Academy of Neurology.

27 Dec 2017

Kessler Foundation wins second Hearst fellowship for cognitive rehabilitation research

Kessler Foundation has been awarded a second two-year $150,000 grant from the Hearst Foundations to support a two-year post-doctoral fellowship in cognitive rehabilitation research.

27 Dec 2017

Neuroscience News and Research

Evidence suggests two patterns of early symptoms precede and predict later BD risk

Study finds overall pattern of commonality between Huntington's and Parkinson's

New study discovers key brain circuit implicated in social behavior

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Kessler Foundation researcher receives grant for study on emotional processing intervention in MS

Family study looks at potential genetic distinctions between bipolar disorder subtypes

Salk scientists identify molecular target of experimental Alzheimer’s drug

Alzheimer’s Research UK calls on pharma to continue supporting dementia research

Vanderbilt and Lundbeck collaborate to develop novel approach for treating schizophrenia

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

Researchers develop drug that supports cellular traffic jam theory in ALS/FTD

WPI professor receives Smith Family Foundation grant to explore biology of cancer cells

Social difficulties of females with autism may be masked during clinical assessments, study finds

Sleeping sickness actually caused by acceleration of biological clocks

Powerful imaging technique sheds light on how the brain responds to vascular injury

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Advanced live cell imaging reveals brain’s response to blood vessel injury

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

New AAN guideline: Exercising twice a week may improve memory in people with MCI

Kessler Foundation wins second Hearst fellowship for cognitive rehabilitation research

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News